CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)
- Conditions
- Colonic Neoplasms
- Interventions
- Procedure: Japanese pathological investigationProcedure: European pathological investigation
- Registration Number
- NCT06119867
- Lead Sponsor
- Russian Society of Colorectal Surgeons
- Brief Summary
In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other hand, involves the intervention of surgeons, particularly in the extraction of lymph nodes from fresh specimens and the assessment of specimen quality. Given that the Japanese pathological assessment method lacks systematic evaluation and there is currently no literature clearly demonstrating its diagnostic accuracy, the main objective of this study is to verify whether the diagnostic accuracy of the Japanese pathological investigation method is inferior to that of the European pathological evaluation method.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 430
- Patients diagnosed with colon cancer who underwent colectomy;
- Patients with pathological confirmed adenocarcinoma;
- Patients agreed to participate in the study.
- Patients suffered from rectal cancer;
- Patients diagnosed with colon cancer but did not undergo colectomy;
- Patients refused participation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Japanese pathological investigation method group Japanese pathological investigation The surgeon will be involved into the Japanese pathological investigation method. The surgeon will perform the intraoperative markings and the postoperative lymph node harvest, after which the specimen will be assessed by the pathologist. European pathological investigation method group European pathological investigation After receiving the resected specimen, the entire process will be independently managed by the pathologist.
- Primary Outcome Measures
Name Time Method Comparision of the incidence of stage III colon cancer between European and Japanese pathological investigation methods. up to 24 months indentification of the rate of postive lymph nodes
- Secondary Outcome Measures
Name Time Method The role of immunohistochemical examination in the Node (N) stage determination up to 24 months indentification of the rate of postive lymph nodes using immunohistochemical examination
Comparison of the resection margin (proximal, distal, circular) between the European and Japanese pathological approaches up to 24 months indentification of the rate of the postive proximal, distal or circular resection margin
Comparison of the lymph node ratio (LNR) between the European and Japanese pathological approaches up to 24 months LNR=Postivie lymph node/ Total retrived lymph node
Comparison of the tumor budding between the European and Japanese pathological approaches up to 24 months indentification of the rate of tumor budding
Comparison of the tumor-infiltrating lymphocytes (TIL) count between the European and Japanese pathological approaches up to 24 months indentification of the rate of the tumor-infiltrating lymphocytes (TIL) count
Comparison of the pT Stage between the European and Japanese pathological approaches up to 24 months indentification of the rate of the pathological T stages
Comparison of the extracapsular invasion between the European and Japanese pathological approaches up to 24 months indentification of the rate of the extracapsular invasion
Comparison of the extramural invasion (venous, lymphatic, perineural) between the European and Japanese pathological approaches up to 24 months indentification of the rate of the venous, lymphatic or perineural extramural invasion
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Clinic of coloproctology and minimally invasive surgery
🇷🇺Moscow, Russian Federation